Ocean Biomedical Inc. (OCEA)

AI Score

Unlock

0.04

-0.00 (-7.41%)

At close: Apr 17, 2025, 3:59 PM

0.04

-3.13%

After-hours: Apr 17, 2025, 07:59 PM EDT

Ocean Biomedical Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	2.04M	-768K	-682K	-595K	660K	-2.65M	-2.68M	-5.22M	-614.18K	-1.37M	-6.9M	-5.11M	-8.18M	-4.89M	-5.34M	-43.94M	-884K	-12K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.02M	351.77K	140.3K	6.91K	2.27K	n/a	n/a	n/a	n/a	n/a
Pretax Income	6.46M	-5.53M	-17.23M	13M	-16.86M	-14.09M	-13.03M	-67.4M	410.05K	-1.02M	-7.33M	-5.38M	-8.18M	-4.89M	-5.34M	-43.94M	-885K	-12K
Net Income	6.46M	-5.53M	-17.23M	13M	-16.86M	-14.09M	-13.03M	-128.04M	410.05K	-1.02M	-7.77M	-5.37M	-8.18M	-4.88M	-5.34M	-43.94M	-886K	-12K
Selling & General & Admin	1.75M	768K	682K	569K	-643K	2.35M	2.65M	4.83M	614.18K	1.37M	3.71M	1.91M	4.98M	2.23M	2.68M	18.53M	835K	12K
Research & Development	n/a	n/a	n/a	26K	-17K	305K	28K	393K	n/a	1.86M	3.19M	3.2M	3.19M	2.66M	2.66M	25.41M	n/a	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	-1K	-12.68M	n/a	1K	-699K	1K	n/a	2K	n/a	n/a	49K	n/a
Operating Expenses	1.75M	768K	682K	595K	-660K	2.65M	2.68M	5.22M	614.18K	1.37M	6.9M	5.11M	8.18M	4.89M	5.34M	43.94M	884K	12K
Interest Expense	433K	461K	515K	637K	500K	293K	668K	1.54M	-624.29K	61K	433K	266K	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	54.6K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.75M	768K	682K	595K	-660K	2.65M	2.68M	5.22M	614.18K	1.37M	6.9M	5.11M	8.18M	4.89M	5.34M	43.94M	884K	12K
Income Tax Expense	-3.3M	n/a	n/a	n/a	n/a	n/a	668K	60.63M	-54.88K	-27.08K	433K	-1K	-69.11K	-2K	1K	-55.21K	1K	-47.3K
Shares Outstanding (Basic)	27.5M	27.49M	27.49M	27.34M	27.34M	26.61M	26.47M	24.82M	13.22M	13.22M	10.6M	20.2M	13.2M	13.47M	13.47M	32.64M	20.2M	32.64M
Shares Outstanding (Diluted)	27.5M	27.49M	27.49M	27.34M	27.34M	26.61M	26.47M	24.82M	13.22M	13.22M	10.6M	20.2M	13.2M	13.47M	13.47M	32.64M	20.2M	32.64M
EPS (Basic)	0.01	-0.2	-0.63	0.48	n/a	-0.53	-0.49	-5.16	0.03	-0.08	-0.73	-0.27	-3.1	-0.36	-0.4	-1.35	-0.04	-0.00
EPS (Diluted)	0.01	-0.2	-0.63	0.48	n/a	-0.53	-0.49	-5.16	0.03	-0.08	-0.73	-0.27	-3.1	-0.36	-0.4	-1.35	-0.04	-0.00
EBITDA	716K	-5.07M	-16.72M	13.64M	-16.36M	-13.79M	-10.76M	-71.79M	15.29M	-3.61M	-7.28M	-5.36M	-8.18M	-4.89M	-5.34M	-43.94M	-884K	-12K
EBIT	716K	-5.07M	-16.72M	13.64M	-16.36M	-13.79M	-10.76M	-71.79M	15.29M	-3.61M	-7.28M	-5.36M	-8.18M	-4.89M	-5.34M	-43.94M	-884K	-12K
Depreciation & Amortization	n/a	n/a	-16.04M	14.23M	-17.02M	-11.14M	-1K	-12.68M	54.88K	27.08K	-1K	1K	71.39K	54K	55.81K	55.21K	55.13K	47.3K